Global and India Digestive Aids Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global and India Digestive Aids Market Report & Forecast 2024-2034
Digestive aids are products, substances, or techniques used to support and improve the process of digestion within the human body.
The global Digestive Aids revenue was US$ 1845 million in 2022 and is forecast to a readjusted size of US$ 4004.7 million by 2029 with a CAGR of 12.6% during the review period (2024-2034).
In India the Digestive Aids revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2024-2034.
Digestive aids are medications used to improve the functioning of the gastrointestinal tract, facilitate the digestion of food and relieve symptoms of indigestion. These medications are widely used in clinical practice, especially in the treatment of gastrointestinal problems, stomach ulcers, heartburn, gastroesophageal reflux disease (GERD) and other digestive disorders. Antacid medications such as proton pump inhibitors (PPIs) and H2 receptor antagonists (H2RAs) remain the mainstay of treatment for GERD and gastric ulcers. Although they are very effective, long-term use can lead to a number of side effects and safety concerns, so researchers are seeking safer alternatives. Probiotics and prebiotics are believed to be beneficial for gut health, improving the balance of intestinal flora and positively affecting digestion and the immune system. These products have become part of the market for digestive aids and new research continues to support their effectiveness. A number of natural herbs and herbal remedies are widely used to treat indigestion and gastrointestinal problems. These include turmeric, peppermint, wormwood and aloe vera. Researchers are delving into the efficacy and safety of these botanical medicines. Overall, the field of digestive aid medications is evolving, with researchers and doctors striving to find safer and more effective treatments, as well as a growing emphasis on the importance of personalised treatment and a healthy diet. In the future, as medical science continues to advance, we can expect to see more innovative and improved digestive aids and treatments.
This report focuses on global and India Digestive Aids market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2024, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Digestive Aids will continue to grow rapidly in the future.
Global Digestive Aids Scope and Market Size
Digestive Aids market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Digestive Aids market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the Digestive Aids market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.
Roche Holding
Abbvie
Bayer
Pfizer
Biogen
Johnson & Johnson
Takeda Pharmaceutical
Amgen
Sanofi
Novozymes
Metagenics
Enzymedica
o., Ltd.
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Yabao Pharmaceutical Group Co., Ltd.
ZhuZhou QianJin Pharmaceutical Co., Ltd.
Zhejiang Yatai Pharmaceutical Co., Ltd.
Zhejiang East-Asia Pharmaceutical Co., Ltd.
Guangdong Sunho Pharmaceutical Co., Ltd.
Cisen Pharmaceutical Co., Ltd.
Hunan Jingfeng Pharmaceutical Co., Ltd.
Tibet Aim Pharm. Inc.
Medifactia
Konsyl Pharmaceuticals,Inc
Segment by Type
Gastrointestinal Dynamics
Digestive Enzyme Drugs
Antacids
Antigastrics
Hospitals
Clinics
Research Institutes
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Digestive Aids definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Digestive Aids companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Digestive Aids in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digestive Aids revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
The global Digestive Aids revenue was US$ 1845 million in 2022 and is forecast to a readjusted size of US$ 4004.7 million by 2029 with a CAGR of 12.6% during the review period (2024-2034).
In India the Digestive Aids revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2024-2034.
Digestive aids are medications used to improve the functioning of the gastrointestinal tract, facilitate the digestion of food and relieve symptoms of indigestion. These medications are widely used in clinical practice, especially in the treatment of gastrointestinal problems, stomach ulcers, heartburn, gastroesophageal reflux disease (GERD) and other digestive disorders. Antacid medications such as proton pump inhibitors (PPIs) and H2 receptor antagonists (H2RAs) remain the mainstay of treatment for GERD and gastric ulcers. Although they are very effective, long-term use can lead to a number of side effects and safety concerns, so researchers are seeking safer alternatives. Probiotics and prebiotics are believed to be beneficial for gut health, improving the balance of intestinal flora and positively affecting digestion and the immune system. These products have become part of the market for digestive aids and new research continues to support their effectiveness. A number of natural herbs and herbal remedies are widely used to treat indigestion and gastrointestinal problems. These include turmeric, peppermint, wormwood and aloe vera. Researchers are delving into the efficacy and safety of these botanical medicines. Overall, the field of digestive aid medications is evolving, with researchers and doctors striving to find safer and more effective treatments, as well as a growing emphasis on the importance of personalised treatment and a healthy diet. In the future, as medical science continues to advance, we can expect to see more innovative and improved digestive aids and treatments.
This report focuses on global and India Digestive Aids market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2024, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Digestive Aids will continue to grow rapidly in the future.
Global Digestive Aids Scope and Market Size
Digestive Aids market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Digestive Aids market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the Digestive Aids market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.
By Company
Roche Holding
Abbvie
Bayer
Pfizer
Biogen
Johnson & Johnson
Takeda Pharmaceutical
Amgen
Sanofi
Novozymes
Metagenics
Enzymedica
o., Ltd.
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Yabao Pharmaceutical Group Co., Ltd.
ZhuZhou QianJin Pharmaceutical Co., Ltd.
Zhejiang Yatai Pharmaceutical Co., Ltd.
Zhejiang East-Asia Pharmaceutical Co., Ltd.
Guangdong Sunho Pharmaceutical Co., Ltd.
Cisen Pharmaceutical Co., Ltd.
Hunan Jingfeng Pharmaceutical Co., Ltd.
Tibet Aim Pharm. Inc.
Medifactia
Konsyl Pharmaceuticals,Inc
Segment by Type
Gastrointestinal Dynamics
Digestive Enzyme Drugs
Antacids
Antigastrics
Segment by Application
Hospitals
Clinics
Research Institutes
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Digestive Aids definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Digestive Aids companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Digestive Aids in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digestive Aids revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices